ABCB1 and familial pancreatic carcinoma: However, despite the expression of P-glycoprotein in the vast majority of pancreatic cancer cells [36], the additive effect of EP and cisplatin obtained in our study cannot be attributed to P-glycoprotein inhibition, especially that the mechanisms of resistance to platinum-based antitumor agents are MDR1-independent [37].